Objective The high burden associated with respiratory syncytial virus (RSV) has made the
development of RSV vaccine (s) a global health high priority. This review summarizes the …

Viral infections account for up to 30% of all infectious complications in lung transplant
recipients, remaining a significant cause of morbidity and even mortality. Impact of viral …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) that causes coronavirus
disease 2019 (COVID‐19) has become a global health problem with pandemic character …

Solid organ transplantation (SOT) is the final therapeutic option for recipients with end-stage
organ failure, and its long-term success is limited by infections and chronic allograft …

Objectives: Summarize the etiology of adenovirus disease. Outline the pathophysiology of
adenovirus. Review the epidemiology of the classic adenovirus disease. Explain the …

Owing to the outbreak of the novel coronavirus (SARS-CoV-2) worldwide at the end of 2019,
the development of a SARS-CoV-2 vaccine became an urgent need. In this study, we …

Introduction Respiratory viral infections (RVI) in lung transplant recipients (LTR) have
variably been associated with rejection and chronic lung allograft dysfunction. Our center …

Background COVID-19 has become a common infection affecting lung transplant recipients
(LTR), who are at high risk for poor outcomes. Outcomes early in the pandemic were poor …

Background In the general population, prior infection with SARS‐CoV‐2 reduces the risk of
severe COVID‐19; however, studies in lung transplant recipients (LTRs) are lacking. We …

Survival in lung transplant recipients (LTRs) lags behind heart, liver, and kidney transplant,
in part due to the direct and indirect effects of infection. LTRs have increased susceptibility to …